- Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experience
-
Prakash G, Jain A, Sahu K, Bal A, Singh C, Basher R, Singh H, Mishra K, Jandial A, Lad D, Khadwal A, Srinivasan R, Das A, Varma N, Varma S, Malhotra P
- KMID: 2520582
- Blood Res.
- 2021 Sep;56(3):134-140.
- doi: 10.5045/br.2021.2021039
Background: This study evaluated the outcomes of patients with refractory/relapsed Hodgkin lymphoma (RRHL) treated with a bendamustine-based regimen in combination with ifosfamide, etoposide, and vinorelbine (VIBE). Methods: Consecutive RRHL patients who... -
- CITED
-
- Close
- SHARE
-
- Close
